CVS' long-time CEO steps down
This article was originally published in The Rose Sheet
Executive Summary
CVS Caremark Corp. Chairman, President and CEO Thomas Ryan will retire from the CEO post in May 2011, the Woonsocket, R.I.-based firm said May 12. Ryan has been with CVS for 36 years, serving 16 years as president. The firm says its board expects Larry Merlo, a 20-year CVS veteran and president of CVS/pharmacy retail operations, to succeed Ryan as CEO. Merlo will continue to serve in his current capacity until the company finds a successor. The firm also announced it formed the Office of the Chairman to aid in the transition; the office will include Ryan, Merlo and Per Lofberg, president of Caremark Pharmacy Services
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.